Metabolism - Clinical and Experimental
Volume 44, Issue 12 , Pages 1553-1558, December 1995

Glucose regulation of glucose transporters in cultured adult and fetal hepatocytes

  • Qingjun Zheng

      Affiliations

    • Pediatric Endocrine Unit, Children's Service, and the Laboratory of Tumor Biology, Cancer Center, Massachusetts General Hospital USA
    • Harvard Medical School, Boston, MA, USA
  • ,
  • Lynne L. Levitsky

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Lynne L. Levitsky, MD, Pediatric Endocrine Unit, Bartlett 4X,, Massachusetts General Hospital, 15 Parkman St, Boston, MA 02114.
    • Pediatric Endocrine Unit, Children's Service, and the Laboratory of Tumor Biology, Cancer Center, Massachusetts General Hospital USA
    • Harvard Medical School, Boston, MA, USA
  • ,
  • Kathy Mink

      Affiliations

    • Pediatric Endocrine Unit, Children's Service, and the Laboratory of Tumor Biology, Cancer Center, Massachusetts General Hospital USA
    • Harvard Medical School, Boston, MA, USA
  • ,
  • David B. Rhoads

      Affiliations

    • Pediatric Endocrine Unit, Children's Service, and the Laboratory of Tumor Biology, Cancer Center, Massachusetts General Hospital USA
    • Harvard Medical School, Boston, MA, USA

Received 16 November 1994; accepted 11 March 1995.

Abstract 

GLUT2 is the major glucose transporter of adult hepatocytes. In vivo, membrane GLUT1 is localized to a ring of perivenous cells and increases slightly after fasting or insulin deprivation. GLUT1 also increases in vitro after prolonged culture of isolated adult hepatocytes. We have previously shown that GLUT1 mRNA, protein, and activity are present in the rat fetal hepatocyte, and that both GLUT1 and GLUT2 are important for the pattern of glucose transport in the fetal hepatocyte. We tested the hypothesis that the postnatal increase in circulating glucose is one of the regulators of the changed pattern of GLUT1 and GLUT2 in the hepatocyte after the fetal to neonatal transition. Fetal and adult rat hepatocytes were cultured for 45 hours in supplemented Dulbecco's modified Eagle's medium at glucose concentrations of 1, 8.3, or 30 mmol/L. Culture at 8.3 and 30 mmol/L glucose diminished GLUT1 mRNA as compared with culture in 1 mmol/L glucose in both fetal and adult hepatocytes (P < .05), but GLUT1 mRNA levels were lower in adult versus fetal hepatocyte cultures at 8.3 and 30 mmol/L (P < .05). Similarly, GLUT1 protein levels were significantly diminished in hepatocytes cultured at higher medium glucose (P < .05 for fetal cells at 30 v 1 mmol/L; P < .05 for adult cells at 8.3 and 30 v 1 mmol/L). GLUT2 mRNA abundance was enhanced by medium glucose in adult hepatocytes (P < .05 at 8.3 and 30 v 1 mmol/L) and was unchanged by medium glucose in fetal hepatocytes. In contrast, GLUT2 protein level was unchanged by medium glucose in adult hepatocytes, and was diminished at 30 mmol/L as compared with 1 mmol/L glucose in fetal hepatocytes (P < .05). In confirmation of these findings, uptake of 2-deoxyglucose (2-DOG) by fetal hepatocytes was significantly diminished after culture in 8.3 or 30 mmol/L glucose versus 1 mmol/L glucose (P < .05 and <.01, respectively). These studies confirm that the fetal hepatocyte glucose transporter pattern could be maintained in part by low fetal portal glucose levels. However, the resistance of the fetal hepatocyte glucose transporter pattern as compared with that of the adult hepatocyte to the effects of hyperglycemia suggests additional undefined control mechanisms.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by Grant No. DK-01392-34 (to K.J. Isselbacher) and a grant from Eli Lilly (L.L.L.).

PII: 0026-0495(95)90074-8

Metabolism - Clinical and Experimental
Volume 44, Issue 12 , Pages 1553-1558, December 1995